Optimizing the Management and Outcomes for Cancer Survivors Transitioning to Follow-up Care (R01 Clinical Trial Required)

The goal is this Funding Opportunity Announcement (FOA) is to support research on survivors of adult onset cancers who are transitioning to follow-up care. Through this FOA, the National Cancer Institute (NCI) intends to stimulate the scientific development of innovative healthcare provider- and healthcare system-level interventions to optimize outcomes. This FOA requests applications that develop and test interventions that foster strong collaborations between oncology and non-oncology providers to optimize follow-up care for adult cancer survivors. Interventions focused on the needs of racial/ethnic minority and medically underserved adult survivors, and/or those receiving care in community settings is of high priority.

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

NIH OER Webmaster FBOWebmaster@OD.NIH.GOV